Melissa Robins, MS
Roswell Park Cancer Institute
Elm & Carlton Sts.
Buffalo,
NY
USA
14263
Papers:
REGORAFENIB USE IN METASTATIC COLORECTAL CANCER AFTER FAILING ALL APPROVED LINES OF THERAPY: ADEQUATE QUALITY OF LIFE AND COST-EFFECTIVE?
Student?
yes
SMDM Member?
yes